Download in electronic PDF format for $25



Search the Complete Journal Archives

Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation

Author(s):  Phan Ha,DeReese Annie,Day A J,Carvalho Maria

Issue:  May/Jun 2014 - Volume 18, Number 3
View All Articles in Issue

Abstract:  Domperidone is a prokinetic agent used as a second-line treatment option for gastroparesis in those unable to tolerate metoclopramide. Via inhibition of dopamine- 2 receptors within the gastrointestinal tract and various parts of the central and peripheral nervous system, domperidone helps to facilitate peristalsis and gastric emptying. A major side effect of domperidone is prolactinemia, allowing it to be used off-label for the purpose of inducing lactation. In the U.S., domperidone is currently not U.S. Food and Drug Administration approved due to various case reports and literature associating the risks of sudden cardiac death and ventricular arrhythmia with the use of domperidone. Despite the evidence against the use of domperidone, it is still being widely used in Canada and Europe for both gastroparesis and to induce milk let-down. This article is a literature review intending to assess the risks associated with the use of domperidone in gastroparesis and lactation.

Related Keywords: Ha Phan, Annie DeReese, PharmD, RPh, A.J. Day, PharmD, RPh, Maria Calvalho, PharmD, MRPharmS, PhD, domperidone, prokinetic agent, dopamine 2 receptors, prolactinemia, lactation induction, U.S. Food and Drug Administration, FDA, sudden cardiac death, arrhythmia, gastrointestinal motility, prolonged QTc interval, breast milk

Related Categories: GASTROENTEROLOGY, ADVERSE DRUG EVENTS, CARDIOLOGY, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, LITERATURE REVIEW

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Phan Ha, DeReese Annie, Day A J, Carvalho Maria May/Jun 2014 203-207 Buy
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane Jan/Feb 2017 22-27 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies Yoch Doug Mar/Apr 2017 95-102 Buy
Case Report: Pediatric Scar Management After Open-heart Surgery Phan Ha, Harger Beau, Estrada Nick Jul/Aug 2016 277-280 Buy
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter Miller David G May/Jun 2014 208 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy